Procurement Summary
Country : Estonia
Summary : Antineoplastic Drugs
Deadline : 07 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 96333682
Document Ref. No. : 73929-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The purpose of this procurement is to conclude a framework contract for the purchase of antineoplastic drugs based on the names and descriptions given in HD Annex 1.
L01AA09Bendamustin
100mginf.
L01AA07Trofosamide
50mg N50tabl.
L01AD01Carmustine
L01AB02Treosulfan
5000mgi/v
1000mgi/v
L01BA01Methotrexate
50mg/2ml inf. conc.
L01BA04Pemetrexed
1000mginf. conc
L01CA04Vinorelbine
50mginf conc
L01CA01Vinblastin
10mg/10mlinf conc
L01CD04Cabazitaxel
60mginf. conc
L01DB03Epirubicin
200mginj
L01DB06Idarubicin
10mginj subst
L01Fx14Polatuzumab vedotin
140mginf. solution powder
30mginf. solution powder
L01xD04Aminolevulinic acid
1.5g oral lahuse powder
L01xC28Durvalumab
500mginf
L01xC82Atesolizumab
1200mg/20mlinf
840mg/14mlinf
1875mg/15ml injection
L01x23Mitotan
500mg N100tabl.
L01x24Pegaspargas
750TU/ml- 5ml injection/inf. solution powder
L02AE03Goserelin
3.6mgimpl caps
L02BA03Fulvestrant
250mgN2injection
L03Ax16Plerixafor
20mg/ml-1.2mlinj.Sol
Doc Title: Antineoplastilised ravimid
Contract Type: supplies
Document Type: Contract Notice
Reference Number: 275430
Contract Type: supplies
Authority Type: body-pl
Doc Title: Antineoplastilised ravimid
Dispatch Date: 2024-02-02
Publish Date: 2024-02-05
Submission Date: 2024-03-07
Documents
Tender Notice